| SC 13G | 2008-05-12 | BAM Opportunity Fund, L.P. | CELL THERAPEUTICS INC | 10,503,254 | 10.0% | EDGAR |
| SC 13G/A | 2008-01-31 | Highbridge International LLC | CELL THERAPEUTICS INC | 75 | 3.4% | EDGAR |
| SC 13G/A | 2007-02-15 | TENOR CAPITAL MANAGEMENT Co., L.P. | CELL THERAPEUTICS INC | 3,662,057 | 2.5% | EDGAR |
| SC 13G/A | 2007-02-14 | Highbridge International LLC | CELL THERAPEUTICS INC | 75 | 5.4% | EDGAR |
| SC 13G/A | 2007-02-14 | SUSSMAN S DONALD | CELL THERAPEUTICS INC | 0 | 0.0% | EDGAR |
| SC 13G/A | 2007-02-14 | Linden Capital L.P. | CELL THERAPEUTICS INC | 0 | 0.0% | EDGAR |
| SC 13G/A | 2007-02-14 | ALEXANDRA GLOBAL MASTER FUND LTD | CELL THERAPEUTICS INC | 1,065,036 | 0.7% | EDGAR |
| SC 13G | 2006-10-24 | NOVARTIS AG | CELL THERAPEUTICS INC | 8,670,520 | 7.3% | EDGAR |
| SC 13G | 2006-05-05 | TENOR CAPITAL MANAGEMENT Co., L.P. | CELL THERAPEUTICS INC | 7,190,411 | 7.1% | EDGAR |
| SC 13G | 2006-05-05 | Highbridge International LLC | CELL THERAPEUTICS INC | 75 | 7.5% | EDGAR |
| SC 13G | 2006-02-15 | Linden Capital L.P. | CELL THERAPEUTICS INC | 7,566,631 | 9.5% | EDGAR |
| SC 13G/A | 2006-02-14 | SUSSMAN S DONALD | CELL THERAPEUTICS INC | 5,201,984 | 6.7% | EDGAR |
| SC 13G | 2005-12-20 | ALEXANDRA GLOBAL MASTER FUND LTD | CELL THERAPEUTICS INC | 3,803,727 | 5.0% | EDGAR |
| SC 13G | 2005-11-10 | SUSSMAN S DONALD | CELL THERAPEUTICS INC | 4,727,477 | 6.4% | EDGAR |
| SC 13G/A | 2005-03-23 | DUQUESNE CAPITAL MANAGEMENT L L C | CELL THERAPEUTICS INC | 200,000 | 0.3% | EDGAR |
| SC 13G/A | 2005-02-14 | SHAKER INVESTMENTS LLC/OH | CELL THERAPEUTICS INC | 2,321,788 | 3.8% | EDGAR |
| SC 13G/A | 2005-02-01 | DUQUESNE CAPITAL MANAGEMENT L L C | CELL THERAPEUTICS INC | 4,208,200 | 6.8% | EDGAR |
| SC 13G | 2005-01-24 | DUQUESNE CAPITAL MANAGEMENT L L C | CELL THERAPEUTICS INC | 3,968,700 | 6.4% | EDGAR |
| SC 13G/A | 2004-08-04 | BB BIOTECH AG | CELL THERAPEUTICS INC | 2,602,000 | 4.4% | EDGAR |
| SC 13G/A | 2004-08-03 | ANGELOS PETER G | CELL THERAPEUTICS INC | 2,535,000 | 5.0% | EDGAR |